Chairman of the Board. Adjunct Professor of Cancer Biology, whose research focuses on rare cancers.
Professor of Oncology and the European key opinion leader of GIST therapies.
Ph.D. student, whose research focus is on new therapeutic targets in GIST.
An innovative Professor of Molecular Precision Medicine.
CEO of Herantis Pharma.